A drug used for cancer therapy has shown promise in reversing kidney damage caused by systemic lupus erythematosus (SLE, or lupus), according to a Yale-led study published April 8 in the journal Science Translational Medicine.
Click here for original story, Drug shows promise in reversing kidney damage caused by lupus
Source: ScienceDaily